Cargando…
SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells
Overcoming drug resistance is an important task for investigators and clinician to achieve successful chemotherapy in cancer patients. Drug resistance is caused by various factors, including the overexpression of P-glycoprotein (P-gp, MDR1). The development of new, useful compounds that overcome dru...
Autores principales: | Seo, Hye-Sook, Ku, Jin Mo, Lee, Hee-Jae, Woo, Jong-Kyu, Cheon, Chunhoo, Kim, Mia, Jang, Bo-Hyoung, Shin, Yong Cheol, Ko, Seong-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686394/ https://www.ncbi.nlm.nih.gov/pubmed/28864784 http://dx.doi.org/10.1042/BSR20170125 |
Ejemplares similares
-
A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003
in Patients With Solid Cancer
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2018) -
Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells
por: Seo, Hye-Sook, et al.
Publicado: (2017) -
SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020)